Encompass Health PE Ratio 2010-2024 | EHC

Current and historical p/e ratio for Encompass Health (EHC) from 2010 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Encompass Health PE ratio as of January 31, 2025 is 22.70.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Encompass Health PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2025-01-31 99.27 23.98
2024-09-30 96.47 $4.14 23.30
2024-06-30 85.49 $3.92 21.81
2024-03-31 82.29 $3.70 22.24
2023-12-31 66.36 $3.47 19.13
2023-09-30 66.65 $3.50 19.04
2023-06-30 67.05 $3.11 21.56
2023-03-31 53.45 $2.70 19.80
2022-12-31 58.93 $2.70 21.83
2022-09-30 44.45 $2.72 16.34
2022-06-30 54.59 $3.27 16.69
2022-03-31 69.26 $3.91 17.71
2021-12-31 63.31 $3.90 16.23
2021-09-30 72.49 $3.77 19.23
2021-06-30 75.09 $3.11 24.15
2020-12-31 79.02 $2.85 27.73
2020-09-30 61.89 $2.67 23.18
2020-06-30 58.73 $2.96 19.84
2020-03-31 60.45 $3.60 16.79
2019-12-31 65.11 $3.65 17.84
2021-03-31 78.54 $4.00 19.63
2019-09-30 59.24 $3.21 18.46
2019-06-30 59.06 $3.12 18.93
2019-03-31 54.20 $3.12 17.37
2018-12-31 57.00 $2.93 19.45
2018-09-30 72.01 $3.26 22.09
2018-06-30 62.35 $3.04 20.51
2018-03-31 52.44 $2.82 18.60
2017-12-31 45.13 $2.68 16.84
2017-09-30 42.12 $2.75 15.32
2017-06-30 43.74 $2.72 16.08
2017-03-31 38.50 $2.67 14.42
2016-12-31 36.88 $2.58 14.30
2016-09-30 36.07 $2.39 15.09
2016-06-30 34.31 $2.27 15.12
2016-03-31 33.07 $2.07 15.97
2015-12-31 30.40 $1.90 16.00
2015-09-30 33.29 $1.85 18.00
2015-06-30 39.72 $1.85 21.47
2015-03-31 38.08 $2.25 16.93
2014-12-31 32.86 $2.29 14.35
2014-09-30 31.36 $1.54 20.37
2014-06-30 30.31 $1.60 18.95
2014-03-31 30.21 $2.41 12.54
2013-12-31 27.88 $2.41 11.57
2013-09-30 28.69 $3.16 9.08
2013-06-30 23.84 $3.02 7.89
2013-03-31 21.83 $1.79 12.19
2012-12-31 17.47 $1.70 10.28
2012-09-30 19.92 $1.72 11.58
2012-06-30 19.25 $1.82 10.58
2012-03-31 16.95 $1.56 10.87
2011-12-31 14.63 $1.90 7.70
2011-09-30 12.36 $8.60 1.44
2011-06-30 21.73 $8.33 2.61
2011-03-31 20.68 $8.60 2.40
2010-12-31 17.14 $8.24 2.08
2010-09-30 15.89 $1.43 11.11
2010-06-30 15.49 $1.28 12.10
2010-03-31 15.48 $0.70 22.11
2009-12-31 15.54 $0.77 20.18
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $9.629B $4.801B
Encompass Health Corporation is a provider of integrated healthcare services. It offers both facility-based and home-based patient care through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The company delivers high-quality, cost-effective, integrated care in the healthcare space. It provides a continuum of facility-based and home-based post-acute services for its patients and their families, which will gain more prevalence as coordinated care and integrated delivery payment models, such as accountable care organizations and bundled payment arrangements. The company operates through two segments: Inpatient Rehabilitation as well as Home Health and Hospice business.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $21.703B 0.00
Quest Diagnostics (DGX) United States $17.349B 17.58
DaVita (DVA) United States $14.249B 18.43
Chemed (CHE) United States $8.394B 25.80
Elanco Animal Health (ELAN) United States $6.076B 14.46
Option Care Health (OPCH) United States $5.267B 24.96
RadNet (RDNT) United States $4.972B 110.11
LifeStance Health (LFST) United States $3.092B 0.00
Amedisys (AMED) United States $3.023B 21.51
Addus HomeCare (ADUS) United States $2.290B 26.87
Astrana Health (ASTH) United States $2.076B 28.39
U.S Physical Therapy (USPH) United States $1.337B 35.14
Pennant (PNTG) United States $0.945B 38.21
Aveanna Healthcare Holdings (AVAH) United States $0.945B 0.00
Atai Life Sciences (ATAI) Germany $0.252B 0.00
Bioqual (BIOQ) United States $0.055B 0.00
Daxor (DXR) United States $0.038B 0.00
Ontrak (OTRK) United States $0.007B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.004B 0.00
IMAC Holdings (BACK) United States $0.002B 0.00
Psychemedics (PMD) United States $0.000B 0.00